ERA4TB launched a series of webinars aimed at exploring key topics in relation to tuberculosis and antimicrobial research and development from clinical, regulatory and HTA perspectives. With the title “Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives”, the first webinar was held on 24th November 2022, 11.00-12.15 GMT coinciding with World Antimicrobial Awareness […]

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on machine learning (ML). First, all attendees introduced themselves and outlined their interest in ML. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions) and Philip Gribbon, SIG Leader, Fraunhofer ITMP introduced the ML Scientific Interest Group (SIG) and its charter. Daniel […]

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on animal models. First, all attendees introduced themselves and outlined which models they currently use in their project. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions), SIG Chairman and Carina Vingsbo Lundberg, SIG Leader, Statens Serum Institut introduced the Animal Models […]

Fourteen partners attended this second meeting of the Machine Learning (ML) Scientific Interest Group (SIG), which focused on the practical application of Artificial Intelligence (AI) and Machine Learning methods in antimicrobial drug discovery (ADD). Artificial intelligence concerns the study and development of machines that are capable of learning and problem-solving, thus natural intelligence. A "worked […]

About ten people attended this second meeting with the Scientific Interest Group (SIG) on animal models. As a follow up from the previous SIG meeting, this event focused on “Data Cataloging of animal infection models.”. The attendees contributed to this first version of the in vivo catalog with information about their resources and infection models […]